These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 29945725)

  • 1. The Increasingly Human and Profitable Monoclonal Antibody Market.
    Grilo AL; Mantalaris A
    Trends Biotechnol; 2019 Jan; 37(1):9-16. PubMed ID: 29945725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging trends and new developments in monoclonal antibodies: A scientometric analysis (1980-2016).
    Lai Y; Wang R; Chen X; Tang D; Hu Y; Cai J; Zhang Q; Hu H
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-10. PubMed ID: 28301271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technological Evolution in the Development of Therapeutic Antibodies.
    Fajardo-Ramírez ÓR; Ascacio-Martínez JA; Licea-Navarro AF; Villela-Martínez LM; Barrera-Saldaña HA
    Rev Invest Clin; 2015; 67(3):158-69. PubMed ID: 26202739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mining Naïve Rabbit Antibody Repertoires by Phage Display for Monoclonal Antibodies of Therapeutic Utility.
    Peng H; Nerreter T; Chang J; Qi J; Li X; Karunadharma P; Martinez GJ; Fallahi M; Soden J; Freeth J; Beerli RR; Grawunder U; Hudecek M; Rader C
    J Mol Biol; 2017 Sep; 429(19):2954-2973. PubMed ID: 28818634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody therapy in multiple myeloma: where do we stand and where are we going?
    Thanendrarajan S; Davies FE; Morgan GJ; Schinke C; Mathur P; Heuck CJ; Zangari M; Epstein J; Yaccoby S; Weinhold N; Barlogie B; van Rhee F
    Immunotherapy; 2016; 8(3):367-84. PubMed ID: 26888183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunomodulation as innovative therapy for head and neck tumors : Current developments].
    Schuler PJ; Doescher JC; Laban S; Hoffmann TK
    HNO; 2016 Jul; 64(7):470-8. PubMed ID: 26912050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bispecific antibodies for viral immunotherapy.
    Nyakatura EK; Soare AY; Lai JR
    Hum Vaccin Immunother; 2017 Apr; 13(4):836-842. PubMed ID: 27786606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges in monoclonal antibody-based therapies.
    Samaranayake H; Wirth T; Schenkwein D; Räty JK; Ylä-Herttuala S
    Ann Med; 2009; 41(5):322-31. PubMed ID: 19234897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Not Available].
    Ostendorf GM
    Versicherungsmedizin; 2016 Mar; 68(1):31-3. PubMed ID: 27111958
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic monoclonal antibodies: a little history, a lot of engineering, and... some clinical successes].
    Siberil S; Dutertre CA; Boix C; Teillaud JL
    Transfus Clin Biol; 2005 Jun; 12(2):114-22. PubMed ID: 15907389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment and treatment trials in multiple sclerosis.
    Kieseier BC; Wiendl H; Hemmer B; Hartung HP
    Curr Opin Neurol; 2007 Jun; 20(3):286-93. PubMed ID: 17495622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G-CSF-stimulated PMN in immunotherapy of breast cancer with a bispecific antibody to Fc gamma RI and to HER-2/neu (MDX-210).
    Repp R; Valerius T; Wieland G; Becker W; Steininger H; Deo Y; Helm G; Gramatzki M; Van de Winkel JG; Lang N
    J Hematother; 1995 Oct; 4(5):415-21. PubMed ID: 8581378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current status and future perspective of cancer immunotherapy--clinical application and development].
    Aruga A
    Nihon Geka Gakkai Zasshi; 2013 Nov; 114(6):327-31. PubMed ID: 24358730
    [No Abstract]   [Full Text] [Related]  

  • 14. Monoclonal antibodies in cancer immunotherapy.
    Kimiz-Gebologlu I; Gulce-Iz S; Biray-Avci C
    Mol Biol Rep; 2018 Dec; 45(6):2935-2940. PubMed ID: 30311129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Immunomodulatory Therapy: An Overview.
    Lefebvre AL; McAuliffe L
    R I Med J (2013); 2016 Dec; 99(12):19-22. PubMed ID: 27902994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody mimicry, receptors and clinical applications.
    Horenstein AL; Chillemi A; Quarona V; Zito A; Mariani V; Faini AC; Morandi F; Schiavoni I; Ausiello CM; Malavasi F
    Hum Antibodies; 2017; 25(3-4):75-85. PubMed ID: 28035914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of anti-NMDA receptor encephalitis without tumor to immunotherapy including rituximab.
    Ishiura H; Matsuda S; Higashihara M; Hasegawa M; Hida A; Hanajima R; Yamamoto T; Shimizu J; Dalmau J; Tsuji S
    Neurology; 2008 Dec; 71(23):1921-3. PubMed ID: 19047564
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimental immunotherapy of colorectal carcinoma by monoclonal antibody ND4.
    Kelly TM; Thomas P; Ganguly A
    Hybridoma (Larchmt); 2007 Feb; 26(1):10-6. PubMed ID: 17316080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies as innovative therapeutics.
    Reichert JM
    Curr Pharm Biotechnol; 2008 Dec; 9(6):423-30. PubMed ID: 19075682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Licensed monoclonal antibodies and associated challenges.
    Khan AH; Sadroddiny E
    Hum Antibodies; 2015 Dec; 23(3-4):63-72. PubMed ID: 27472864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.